On June 19th 2019, The New York State Department of Health (DOH) issued an advisory regarding a shortage of purified protein derivative (PPD) solution for tuberculin skin testing, in response to an anticipated three- to 10-month Aplisol® shortage. The DOH is temporarily recommending an adjustment to tuberculosis (TB)-testing procedures for employee testing programs if institutions experience a shortage of testing product.
New York State regulations still require serial testing for health care personnel in various clinical settings. However, in facilities experiencing a shortage of PPD testing solution, repeat testing can be deferred for persons with the appropriate baseline testing and no new risk for infection or disease on annual assessment.
Sumer King, Zeynep et al. New York State DOH Guidance on Shortage of Tuberculin Skin Test Solution. Greater New York Hospital Association (2019). https://www.gnyha.org/news/new-york-state-doh-guidance-on-shortage-of-tuberculin-skin-test-solution/